Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$333M |
| 2 |
Alibaba
BABA
|
+$303M |
| 3 |
Pfizer
PFE
|
+$269M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
Eversource Energy
ES
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$780M |
| 2 |
Linde
LIN
|
+$623M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$515M |
| 4 |
S&P Global
SPGI
|
+$449M |
| 5 |
UnitedHealth
UNH
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.66% |
| 2 | Healthcare | 13.63% |
| 3 | Financials | 11.69% |
| 4 | Communication Services | 9.98% |
| 5 | Consumer Discretionary | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBTM
2101
JBT Marel
JBTM
$7.21B
| $1.36M | ﹤0.01% |
12,129
+2,416
| +25% | +$259K |
|
2102
Viking Therapeutics
VKTX
$3.7B
| $1.36M | ﹤0.01% |
169,904
+4,797
| +3% | +$35K |
|
2103
FormFactor
FORM
$8.28B
| $1.36M | ﹤0.01% |
52,463
+28,665
| +120% | +$647K |
|
|
AAMI
2104
Acadian Asset Management
AAMI
$3.08B
| $1.36M | ﹤0.01% |
132,893
+3,182
| +2% | +$31K |
|
2105
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.01B
| $1.35M | ﹤0.01% |
69,148
+17,800
| +35% | +$348K |
|
2106
Oil States International
OIS
$489M
| $1.35M | ﹤0.01% |
82,906
+21,877
| +36% | +$332K |
|
2107
Tanger
SKT
$4.67B
| $1.35M | ﹤0.01% |
91,682
-10,330
| -10% | -$162K |
|
2108
Abeona Therapeutics
ABEO
$366M
| $1.34M | ﹤0.01% |
16,471
+10,316
| +168% | +$728K |
|
2109
Ecovyst
ECVT
$1.32B
| $1.34M | ﹤0.01% |
78,179
+63,610
| +437% | +$1.02M |
|
2110
ScottsMiracle-Gro
SMG
$3.82B
| $1.34M | ﹤0.01% |
12,658
-35,139
| -74% | -$3.59M |
|
|
PETQ
2111
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.34M | ﹤0.01% |
53,581
-30,679
| -36% | -$762K |
|
2112
Hope Bancorp
HOPE
$1.79B
| $1.34M | ﹤0.01% |
90,237
+15,160
| +20% | +$220K |
|
2113
Neogen
NEOG
$2.63B
| $1.34M | ﹤0.01% |
40,988
-1,002
| -2% | -$32.9K |
|
|
HIBB
2114
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.34M | ﹤0.01% |
47,749
-20,663
| -30% | -$524K |
|
2115
Adeia
ADEA
$2.94B
| $1.33M | ﹤0.01% |
273,271
-99,879
| -27% | -$530K |
|
|
GNMK
2116
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.33M | ﹤0.01% |
276,161
+16,879
| +7% | +$93.1K |
|
|
SPAQ.U
2117
DELISTED
Spartan Energy Acquisition Corp Units (each consisting of one Class A Common Stock and one-third of
SPAQ.U
| $1.33M | ﹤0.01% |
130,001
-999,999
| -88% | -$10.3M |
|
2118
Yext
YEXT
$547M
| $1.32M | ﹤0.01% |
91,990
-269,893
| -75% | -$4.19M |
|
2119
Rogers Corp
ROG
$2.21B
| $1.32M | ﹤0.01% |
10,591
-13,498
| -56% | -$1.82M |
|
2120
Medpace
MEDP
$16.1B
| $1.32M | ﹤0.01% |
15,698
-8,286
| -35% | -$641K |
|
|
INN
2121
Summit Hotel Properties
INN
$746M
| $1.32M | ﹤0.01% |
106,880
-44,893
| -30% | -$539K |
|
2122
Prothena Corp
PRTA
$425M
| $1.31M | ﹤0.01% |
82,984
-71,250
| -46% | -$764K |
|
2123
Vericel Corp
VCEL
$2.35B
| $1.31M | ﹤0.01% |
75,573
+45,668
| +153% | +$777K |
|
2124
Independent Bank
INDB
$3.99B
| $1.31M | ﹤0.01% |
15,716
-477
| -3% | -$39K |
|
2125
Accuray
ARAY
$32M
| $1.3M | ﹤0.01% |
463,231
+189,804
| +69% | +$527K |
|
Similar funds
Deutsche Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Deutsche Bank held 5,318 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Deutsche Bank withdrew a net $5.3B in Q4 2019, closing 262 positions and reducing 1,924 holdings. Its most notable exit was Celgene Corp, an estimated $273M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Deutsche Bank opened a new position in XP worth $32.9M.
- Deutsche Bank's largest Q4 2019 buy was XP: 853,950 shares worth $32.9M.
- Deutsche Bank added most to Johnson & Johnson in Q4 2019, an estimated $333M increase.
- Deutsche Bank's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $780M.
- Deutsche Bank fully exited Celgene Corp in Q4 2019, selling an estimated $273M.
- Deutsche Bank's ten largest holdings make up 17% of its $153B portfolio in Q4 2019.
- Deutsche Bank opened 407 new positions and closed 262 in Q4 2019.
- Deutsche Bank's portfolio value rose 6.6% quarter-over-quarter to $153B.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.